Aspira Pathlab & Diagnostics fundamental analysis

123

2.00 (-1.60%)
Last updated on 9 Jun, 2026 | 13:15 IST
Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Aspira Pathlab & Diagnostics Score Card

  • price_icon
    Price

    Expensive

  • chart_icon
    Growth

    Good

  • quality_check
    Quality

    Average

  • quality_check
    Management

    Average

On its scorecard, Aspira Pathlab & Diagnostics reflects: Price – Expensive, Growth – Good, Quality – Average, and Management – Average. Together, these indicators provide a structured view of the company’s fundamentals.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost
Invest Now